nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.332	1	CbGbCtD
Mianserin—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0267	0.0852	CbGeAlD
Mianserin—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.014	0.0447	CbGeAlD
Mianserin—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0112	0.0356	CbGeAlD
Mianserin—HTR7—pons—amyotrophic lateral sclerosis	0.011	0.0352	CbGeAlD
Mianserin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0086	0.0353	CcSEcCtD
Mianserin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00774	0.0318	CcSEcCtD
Mianserin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0316	CcSEcCtD
Mianserin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00752	0.0309	CcSEcCtD
Mianserin—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00736	0.0235	CbGeAlD
Mianserin—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00734	0.0234	CbGeAlD
Mianserin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0294	CcSEcCtD
Mianserin—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00696	0.0222	CbGeAlD
Mianserin—HTR2A—pons—amyotrophic lateral sclerosis	0.00688	0.0219	CbGeAlD
Mianserin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0068	0.0279	CcSEcCtD
Mianserin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00617	0.0253	CcSEcCtD
Mianserin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00608	0.025	CcSEcCtD
Mianserin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00599	0.0246	CcSEcCtD
Mianserin—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00593	0.0189	CbGeAlD
Mianserin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00591	0.0243	CcSEcCtD
Mianserin—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00587	0.0187	CbGeAlD
Mianserin—HTR7—nerve—amyotrophic lateral sclerosis	0.00572	0.0182	CbGeAlD
Mianserin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0232	CcSEcCtD
Mianserin—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00551	0.0176	CbGeAlD
Mianserin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00548	0.0225	CcSEcCtD
Mianserin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00541	0.0222	CcSEcCtD
Mianserin—DRD2—nerve—amyotrophic lateral sclerosis	0.00541	0.0172	CbGeAlD
Mianserin—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00538	0.0172	CbGeAlD
Mianserin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0217	CcSEcCtD
Mianserin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0214	CcSEcCtD
Mianserin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00511	0.021	CcSEcCtD
Mianserin—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00505	0.0161	CbGeAlD
Mianserin—HTR2A—appendage—amyotrophic lateral sclerosis	0.00503	0.016	CbGeAlD
Mianserin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00486	0.02	CcSEcCtD
Mianserin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00483	0.0198	CcSEcCtD
Mianserin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00472	0.0194	CcSEcCtD
Mianserin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0193	CcSEcCtD
Mianserin—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00457	0.0146	CbGeAlD
Mianserin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00456	0.0187	CcSEcCtD
Mianserin—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00448	0.0143	CbGeAlD
Mianserin—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00428	0.0137	CbGeAlD
Mianserin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0174	CcSEcCtD
Mianserin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00419	0.0172	CcSEcCtD
Mianserin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0171	CcSEcCtD
Mianserin—HTR1F—nervous system—amyotrophic lateral sclerosis	0.00407	0.013	CbGeAlD
Mianserin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0167	CcSEcCtD
Mianserin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0167	CcSEcCtD
Mianserin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0166	CcSEcCtD
Mianserin—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00405	0.0129	CbGeAlD
Mianserin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0163	CcSEcCtD
Mianserin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0161	CcSEcCtD
Mianserin—HTR1F—central nervous system—amyotrophic lateral sclerosis	0.00392	0.0125	CbGeAlD
Mianserin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0161	CcSEcCtD
Mianserin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0158	CcSEcCtD
Mianserin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0158	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0157	CcSEcCtD
Mianserin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0155	CcSEcCtD
Mianserin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00373	0.0153	CcSEcCtD
Mianserin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0152	CcSEcCtD
Mianserin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0149	CcSEcCtD
Mianserin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0149	CcSEcCtD
Mianserin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0149	CcSEcCtD
Mianserin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0148	CcSEcCtD
Mianserin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0147	CcSEcCtD
Mianserin—HTR2A—nerve—amyotrophic lateral sclerosis	0.00357	0.0114	CbGeAlD
Mianserin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00345	0.0142	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0138	CcSEcCtD
Mianserin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0136	CcSEcCtD
Mianserin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0135	CcSEcCtD
Mianserin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0131	CcSEcCtD
Mianserin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0131	CcSEcCtD
Mianserin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00316	0.013	CcSEcCtD
Mianserin—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00316	0.0101	CbGeAlD
Mianserin—HTR1F—brain—amyotrophic lateral sclerosis	0.00311	0.00992	CbGeAlD
Mianserin—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00308	0.00983	CbGeAlD
Mianserin—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00305	0.00973	CbGeAlD
Mianserin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00305	0.0125	CcSEcCtD
Mianserin—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00289	0.00922	CbGeAlD
Mianserin—DRD3—nervous system—amyotrophic lateral sclerosis	0.00287	0.00917	CbGeAlD
Mianserin—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00277	0.00882	CbGeAlD
Mianserin—HTR6—nervous system—amyotrophic lateral sclerosis	0.00277	0.00882	CbGeAlD
Mianserin—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00267	0.00852	CbGeAlD
Mianserin—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00266	0.00849	CbGeAlD
Mianserin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0109	CcSEcCtD
Mianserin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0107	CcSEcCtD
Mianserin—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00257	0.00819	CbGeAlD
Mianserin—OPRK1—nervous system—amyotrophic lateral sclerosis	0.00256	0.00817	CbGeAlD
Mianserin—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00255	0.00812	CbGeAlD
Mianserin—HRH2—nervous system—amyotrophic lateral sclerosis	0.00253	0.00807	CbGeAlD
Mianserin—OPRK1—central nervous system—amyotrophic lateral sclerosis	0.00247	0.00787	CbGeAlD
Mianserin—HTR7—brainstem—amyotrophic lateral sclerosis	0.00246	0.00783	CbGeAlD
Mianserin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00244	0.01	CcSEcCtD
Mianserin—HRH2—central nervous system—amyotrophic lateral sclerosis	0.00244	0.00777	CbGeAlD
Mianserin—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00243	0.00776	CbGeAlD
Mianserin—OPRK1—cerebellum—amyotrophic lateral sclerosis	0.00241	0.00769	CbGeAlD
Mianserin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00957	CcSEcCtD
Mianserin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00956	CcSEcCtD
Mianserin—DRD2—brainstem—amyotrophic lateral sclerosis	0.00232	0.0074	CbGeAlD
Mianserin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00951	CcSEcCtD
Mianserin—DRD3—brain—amyotrophic lateral sclerosis	0.0022	0.00701	CbGeAlD
Mianserin—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00213	0.00679	CbGeAlD
Mianserin—HTR6—brain—amyotrophic lateral sclerosis	0.00212	0.00674	CbGeAlD
Mianserin—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00196	0.00626	CbGeAlD
Mianserin—OPRK1—brain—amyotrophic lateral sclerosis	0.00196	0.00624	CbGeAlD
Mianserin—HRH2—brain—amyotrophic lateral sclerosis	0.00193	0.00617	CbGeAlD
Mianserin—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.0019	0.00605	CbGeAlD
Mianserin—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.0018	0.00574	CbGeAlD
Mianserin—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00178	0.00566	CbGeAlD
Mianserin—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00171	0.00546	CbGeAlD
Mianserin—HTR2A—embryo—amyotrophic lateral sclerosis	0.00167	0.00533	CbGeAlD
Mianserin—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00165	0.00527	CbGeAlD
Mianserin—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00161	0.00515	CbGeAlD
Mianserin—HTR2C—nervous system—amyotrophic lateral sclerosis	0.0016	0.0051	CbGeAlD
Mianserin—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.0016	0.00509	CbGeAlD
Mianserin—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00159	0.00508	CbGeAlD
Mianserin—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00157	0.00502	CbGeAlD
Mianserin—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00156	0.00496	CbGeAlD
Mianserin—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00496	CbGeAlD
Mianserin—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00154	0.00491	CbGeAlD
Mianserin—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00153	0.00488	CbGeAlD
Mianserin—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00153	0.00487	CbGeAlD
Mianserin—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00152	0.00483	CbGeAlD
Mianserin—HTR2B—nervous system—amyotrophic lateral sclerosis	0.0015	0.00479	CbGeAlD
Mianserin—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00465	CbGeAlD
Mianserin—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00145	0.00461	CbGeAlD
Mianserin—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.0014	0.00447	CbGeAlD
Mianserin—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00139	0.00445	CbGeAlD
Mianserin—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00135	0.00429	CbGeAlD
Mianserin—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00133	0.00426	CbGeAlD
Mianserin—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.0013	0.00413	CbGeAlD
Mianserin—HTR7—nervous system—amyotrophic lateral sclerosis	0.00129	0.0041	CbGeAlD
Mianserin—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00128	0.0041	CbGeAlD
Mianserin—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00127	0.00404	CbGeAlD
Mianserin—SLC6A3—brain—amyotrophic lateral sclerosis	0.00126	0.00403	CbGeAlD
Mianserin—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00126	0.004	CbGeAlD
Mianserin—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00124	0.00395	CbGeAlD
Mianserin—HTR1D—brain—amyotrophic lateral sclerosis	0.00123	0.00394	CbGeAlD
Mianserin—HTR2C—brain—amyotrophic lateral sclerosis	0.00122	0.0039	CbGeAlD
Mianserin—DRD2—nervous system—amyotrophic lateral sclerosis	0.00122	0.00388	CbGeAlD
Mianserin—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00121	0.00386	CbGeAlD
Mianserin—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00118	0.00377	CbGeAlD
Mianserin—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00117	0.00373	CbGeAlD
Mianserin—SLC6A4—brain—amyotrophic lateral sclerosis	0.00116	0.00369	CbGeAlD
Mianserin—HTR2B—brain—amyotrophic lateral sclerosis	0.00115	0.00366	CbGeAlD
Mianserin—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00114	0.00365	CbGeAlD
Mianserin—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00114	0.00363	CbGeAlD
Mianserin—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00112	0.00357	CbGeAlD
Mianserin—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00111	0.00355	CbGeAlD
Mianserin—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00107	0.0034	CbGeAlD
Mianserin—HTR1A—brain—amyotrophic lateral sclerosis	0.00103	0.00328	CbGeAlD
Mianserin—SLC6A2—brain—amyotrophic lateral sclerosis	0.00102	0.00325	CbGeAlD
Mianserin—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000983	0.00314	CbGeAlD
Mianserin—HTR7—brain—amyotrophic lateral sclerosis	0.000983	0.00313	CbGeAlD
Mianserin—HRH1—nervous system—amyotrophic lateral sclerosis	0.00096	0.00306	CbGeAlD
Mianserin—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000952	0.00304	CbGeAlD
Mianserin—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000947	0.00302	CbGeAlD
Mianserin—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000943	0.00301	CbGeAlD
Mianserin—DRD2—brain—amyotrophic lateral sclerosis	0.00093	0.00296	CbGeAlD
Mianserin—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000925	0.00295	CbGeAlD
Mianserin—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000908	0.0029	CbGeAlD
Mianserin—ADRA2C—brain—amyotrophic lateral sclerosis	0.000904	0.00288	CbGeAlD
Mianserin—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000888	0.00283	CbGeAlD
Mianserin—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000802	0.00256	CbGeAlD
Mianserin—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000772	0.00246	CbGeAlD
Mianserin—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000755	0.00241	CbGeAlD
Mianserin—CYP2B6—brain—amyotrophic lateral sclerosis	0.000752	0.0024	CbGeAlD
Mianserin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000743	0.00237	CbGeAlD
Mianserin—HRH1—brain—amyotrophic lateral sclerosis	0.000734	0.00234	CbGeAlD
Mianserin—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000731	0.00233	CbGeAlD
Mianserin—ADRA2A—brain—amyotrophic lateral sclerosis	0.000721	0.0023	CbGeAlD
Mianserin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000715	0.00228	CbGeAlD
Mianserin—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000704	0.00224	CbGeAlD
Mianserin—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000688	0.00219	CbGeAlD
Mianserin—HTR2A—brain—amyotrophic lateral sclerosis	0.000613	0.00195	CbGeAlD
Mianserin—CYP2D6—brain—amyotrophic lateral sclerosis	0.000559	0.00178	CbGeAlD
Mianserin—HTR1F—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.24e-05	0.000384	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.22e-05	0.000382	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.21e-05	0.000382	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.19e-05	0.00038	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.18e-05	0.000379	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.16e-05	0.000377	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000375	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.12e-05	0.000373	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.12e-05	0.000373	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.09e-05	0.000371	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.08e-05	0.000369	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.05e-05	0.000366	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.03e-05	0.000365	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.02e-05	0.000364	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.02e-05	0.000364	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.95e-05	0.000358	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.95e-05	0.000358	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.92e-05	0.000355	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.92e-05	0.000355	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.91e-05	0.000354	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.87e-05	0.000351	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.83e-05	0.000347	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.82e-05	0.000346	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.81e-05	0.000345	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.79e-05	0.000344	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.76e-05	0.000341	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.71e-05	0.000336	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.68e-05	0.000333	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.67e-05	0.000333	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.66e-05	0.000331	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.65e-05	0.000331	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.59e-05	0.000325	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.58e-05	0.000325	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.58e-05	0.000324	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.56e-05	0.000322	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.56e-05	0.000322	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.55e-05	0.000322	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.54e-05	0.000321	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.53e-05	0.00032	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.53e-05	0.000319	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.5e-05	0.000317	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.5e-05	0.000317	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.5e-05	0.000317	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.5e-05	0.000317	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.49e-05	0.000316	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.47e-05	0.000314	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.42e-05	0.000309	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.41e-05	0.000308	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.4e-05	0.000308	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.37e-05	0.000305	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.33e-05	0.000302	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.32e-05	0.000301	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.32e-05	0.000301	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.31e-05	0.0003	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.31e-05	0.000299	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.29e-05	0.000298	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.27e-05	0.000296	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.23e-05	0.000292	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.22e-05	0.000292	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.2e-05	0.00029	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.19e-05	0.000289	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.18e-05	0.000288	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.17e-05	0.000288	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.17e-05	0.000287	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.16e-05	0.000286	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.14e-05	0.000285	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.11e-05	0.000282	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.1e-05	0.000281	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.09e-05	0.00028	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.05e-05	0.000276	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.05e-05	0.000276	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.04e-05	0.000275	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.03e-05	0.000274	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3e-05	0.000272	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3e-05	0.000271	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.98e-05	0.000269	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.95e-05	0.000267	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.95e-05	0.000267	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.95e-05	0.000267	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.94e-05	0.000266	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.93e-05	0.000266	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.93e-05	0.000265	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.92e-05	0.000264	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.91e-05	0.000264	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.89e-05	0.000262	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.86e-05	0.000259	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.84e-05	0.000257	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.82e-05	0.000255	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.81e-05	0.000255	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.77e-05	0.000251	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.77e-05	0.000251	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.76e-05	0.00025	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.76e-05	0.00025	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.73e-05	0.000247	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.73e-05	0.000247	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.71e-05	0.000245	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.71e-05	0.000245	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.69e-05	0.000244	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.69e-05	0.000243	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.68e-05	0.000243	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.68e-05	0.000242	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.64e-05	0.000239	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.63e-05	0.000238	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.63e-05	0.000238	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.61e-05	0.000237	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.6e-05	0.000235	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.58e-05	0.000234	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.55e-05	0.000231	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.00023	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.53e-05	0.000229	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.53e-05	0.000229	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.52e-05	0.000228	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	2.52e-05	0.000228	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.51e-05	0.000228	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.49e-05	0.000226	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.49e-05	0.000226	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.48e-05	0.000224	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000222	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.44e-05	0.000221	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.43e-05	0.00022	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.4e-05	0.000217	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.38e-05	0.000215	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.36e-05	0.000213	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.35e-05	0.000213	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	2.35e-05	0.000213	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	2.34e-05	0.000212	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.32e-05	0.00021	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.31e-05	0.000209	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.29e-05	0.000208	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.29e-05	0.000207	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.29e-05	0.000207	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.26e-05	0.000205	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.26e-05	0.000204	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.26e-05	0.000204	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.25e-05	0.000204	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.25e-05	0.000204	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.25e-05	0.000204	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.24e-05	0.000203	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.17e-05	0.000197	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.16e-05	0.000196	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.16e-05	0.000196	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.16e-05	0.000195	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.14e-05	0.000194	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.12e-05	0.000192	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.12e-05	0.000192	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.1e-05	0.00019	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.09e-05	0.00019	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.06e-05	0.000186	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.05e-05	0.000186	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.02e-05	0.000183	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.01e-05	0.000182	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.99e-05	0.00018	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.96e-05	0.000177	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.93e-05	0.000175	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.92e-05	0.000174	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.92e-05	0.000174	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.91e-05	0.000173	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.91e-05	0.000173	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.9e-05	0.000172	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.88e-05	0.00017	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.87e-05	0.00017	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.87e-05	0.000169	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.78e-05	0.000161	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.77e-05	0.000161	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.76e-05	0.00016	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.75e-05	0.000158	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.74e-05	0.000158	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.74e-05	0.000157	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.73e-05	0.000157	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.73e-05	0.000157	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.73e-05	0.000156	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.72e-05	0.000156	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.71e-05	0.000155	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.67e-05	0.000151	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.67e-05	0.000151	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.66e-05	0.00015	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.64e-05	0.000149	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.64e-05	0.000148	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.64e-05	0.000148	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.63e-05	0.000147	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.62e-05	0.000146	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.61e-05	0.000146	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.6e-05	0.000145	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.59e-05	0.000144	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.59e-05	0.000144	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.5e-05	0.000136	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.5e-05	0.000136	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.5e-05	0.000135	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.47e-05	0.000134	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.47e-05	0.000133	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.47e-05	0.000133	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.47e-05	0.000133	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.46e-05	0.000132	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.45e-05	0.000131	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.44e-05	0.000131	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.44e-05	0.00013	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.39e-05	0.000126	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.39e-05	0.000126	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.35e-05	0.000122	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.33e-05	0.000121	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.31e-05	0.000119	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.3e-05	0.000118	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.29e-05	0.000116	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.28e-05	0.000116	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.000115	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.26e-05	0.000114	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.25e-05	0.000113	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.24e-05	0.000113	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000112	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.000111	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.21e-05	0.00011	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.21e-05	0.000109	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.18e-05	0.000106	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.13e-05	0.000102	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.13e-05	0.000102	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.13e-05	0.000102	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.11e-05	0.000101	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.11e-05	0.000101	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.11e-05	0.000101	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.11e-05	0.0001	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.1e-05	0.0001	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.09e-05	9.88e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.09e-05	9.83e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.07e-05	9.69e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.07e-05	9.66e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.06e-05	9.56e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.05e-05	9.5e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.05e-05	9.5e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.05e-05	9.48e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.02e-05	9.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.01e-05	9.15e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.84e-06	8.91e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.58e-06	8.67e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.55e-06	8.65e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.46e-06	8.56e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.42e-06	8.53e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.4e-06	8.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.57e-06	7.76e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.54e-06	7.73e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.48e-06	7.68e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.24e-06	7.46e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.2e-06	7.43e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	8.09e-06	7.33e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.98e-06	7.22e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.24e-06	6.55e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.19e-06	6.51e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.12e-06	6.45e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.11e-06	6.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.48e-06	5.87e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.55e-06	5.02e-05	CbGpPWpGaD
